A It is a weak hypopigmenting agent

B It inhibits tyrosinase

C Response is incomplete and pigmentation may recur

D It should not be used for melasma or chloasma of pregnancy

A Follows saturation kinetics

B Is teratogenic

C Is highly protein bound

D Stimulates Insulin secretion

A Insulinoma

B Glucagonoma

C Glioma

D Carcinoids

A Increased hea rate

B Increased RR interval in ECG

C Increased cardiac output

D Increased force of contraction

A Cisapride

B Famotidine

C Lansoprazole

D Metoclopramide

A Monoamine oxidase

B Alcohol dehydrogenase

C Cytochrome P-450

D Phosphodiesterase

A Pyrimethamine

B Albendazole

C Sodium stibogluconate

D Tinidazole

A Clearance remains constant

B Fixed amount of the drug is eliminated

C Half life increase with dose

D Decreased clearance with increasing dose

A Timolol

B Laevobuno I ol

C Caeolol

D Betaxolol

A Inferomedial

B Superomedial

C Superolateral

D Superomedial